OraSure Technologies Engages Investors at Key Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a renowned leader in diagnostic tests and sample management solutions, is set to make waves at an upcoming investment event. The company has confirmed its participation in the Stephens Annual Investment Conference, which is slated to take place soon. This is an excellent opportunity for the company to engage with potential investors and share the latest advancements in its offerings.
Details of the Conference
The Stephens Annual Investment Conference is a significant event in the financial calendar, gathering key players from various sectors. OraSure's scheduled Q&A session will take place at 10 a.m. CT. This session promises insightful discussions around the company's latest initiatives and future directions.
The Importance of Webcasts
For those unable to attend the conference in person, OraSure will provide a live webcast of the Q&A session. This allows investors and interested parties to access real-time information and insights from the comfort of their locations. Additionally, a replay will be available on OraSure’s investor relations website, ensuring that the valuable information shared during the session can be accessed later as well.
Transformation in Health Care
At the heart of OraSure Technologies' mission is a commitment to transforming healthcare through innovation. The company emphasizes decentralizing diagnostics to make healthcare more accessible. This transformation is crucial in today's fast-paced world, where timely access to health information can significantly influence patient outcomes.
Innovative Solutions and Global Reach
With a strong portfolio, OraSure Technologies, alongside its subsidiaries such as DNA Genotek Inc. and Sherlock Biosciences, is dedicated to delivering solutions that can detect critical medical conditions swiftly. Their products, including rapid diagnostic tests and sample collection devices, have a global reach. They serve various clients, including clinical laboratories, hospitals, and public health organizations.
Engagement with Global Customers
OraSure Technologies prides itself on its ability to cater to a diverse customer base. Their solutions not only assist clinical settings but also empower individuals with direct access to diagnostic services. This focus on user-centered design and functionality sets them apart in the healthcare landscape.
Investor and Media Relations
The company maintains a robust communication strategy with both its investors and the media. Jason Plagman, the Vice President of Investor Relations, oversees the investor communications. Meanwhile, Amy Koch leads the corporate communications team, ensuring that updates are effectively shared with the media and the public.
Contact for More Information
For any inquiries, investors can reach out via the provided contact information. Whether it's about investment opportunities or media-related questions, both teams are equipped to respond and engage effectively.
Frequently Asked Questions
What is the purpose of OraSure’s participation in the investment conference?
OraSure aims to engage with investors, share insights about its advancements, and illustrate its commitment to innovating healthcare solutions.
How can I access the Q&A session if I cannot attend the conference?
A live webcast will be available during the conference, and a replay will be accessible on OraSure's investor relations page afterward.
What kind of products does OraSure Technologies offer?
OraSure offers a variety of rapid diagnostic tests and sample collection solutions that are used globally across healthcare settings.
Who can I contact for more information regarding investments?
You can contact Jason Plagman, VP of Investor Relations, through the company's investor contact email for inquiries about investments.
What is OraSure's mission regarding healthcare?
OraSure is dedicated to transforming healthcare by improving access, quality, and value through innovative diagnostic solutions that decentralize diagnostics.
